Detail of > 305-03-3
- MSDS Download

- CAS Number:
- 305-03-3
- Name:
Benzenebutanoic acid,4-[bis(2-chloroethyl)amino]-
- Superlist Name:
- Chlorambucil
- Formula:
- C14H19Cl2NO2
- Molecular Structure:
![Molecular Structure of 305-03-3 (Benzenebutanoic acid,4-[bis(2-chloroethyl)amino]-)](http://www.lookchem.com/300w/2010/0620/305-03-3.jpg)
- Synonyms:
- Butyricacid, 4-[p-[bis(2-chloroethyl)amino]phenyl]- (8CI);4-[Bis(2-chloroethyl)amino]benzenebutanoic acid;Ambochlorin;Amboclorin;CB 1348;Chloraminophene;Ecloril;Leukeran;Leukeran Tablets;Linfolizin;Linfolysin;Lympholysin;NCI 3088;NSC 3088;g-[p-Di(2-chloroethyl)aminophenyl]butyricacid;
- Molecular Weight:
- 304.24
- EINECS:
- 206-162-0
- Density:
- 1.248 g/cm3
- Melting Point:
- 65-70 °C
- Boiling Point:
- 460.09 °C at 760 mmHg
- Flash Point:
- 232.054 °C
- Solubility:
- <0.01 g/100 mL at 22 °C in water
- Appearance:
- beige powder
- Hazard Symbols:
T- Risk Codes:
- 45-25-36/37/38
- Safety:
- 53-26-45Details
- Transport Information:
- UN 2811 6.1/PG 3
Related products
- 305-03-3Benzenebutanoic acid,4-[bis(2-chloroethyl)amino]-
- 83626-91-9Octanoic acid,4-[bis(2-chloroethyl)amino]phenyl ester
- 64779-10-8Benzenebutanoic acid,4-octyl-g-oxo-
- 189693-74-1Benzenebutanoic acid, b-amino-4-methoxy-
- 7021-11-6Benzenebutanoic acid,4-hydroxy-
- 41826-92-0Benzenebutanoic acid,2,4,5-triethoxy-g-oxo-
- 936630-57-8Benzenebutanoic acid, b-amino-2,4,5-trifluoro-, (bR)-
- 186320-14-9Benzenebutanoic acid,4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-
Other Products
- Titanium Dioxide Carbon black Glutathione Adenosine Cable pulling lubricant
- 1875-50-91H-Inden-1-amine,2,3-dihydro-N-2-propyn-1-yl-
- 305-03-3Benzenebutanoic acid,4-[bis(2-chloroethyl)amino]-
- 4860-03-1Hexadecane,1-chloro-
- 13813-45-1Lutetium iodide (LuI3)
- 6974-12-52-Butene, 1,4-dibromo-
- 36810-87-4Furan,tetrahydro-2-(isothiocyanatomethyl)-
- 75-43-4Methane,dichlorofluoro-
- 4170-30-32-Butenal
- 95648-77-4Inosine5'-(tetrahydrogen triphosphate), 2'-deoxy-, trisodium salt (9CI)
- 943-15-7Benzene,1-methyl-4-(1-methylethyl)-2-nitro-
- 23210-56-21-Piperidineethanol, a-(4-hydroxyphenyl)-b-methyl-4-(phenylmethyl)-
- 10025-97-5Iridium chloride(IrCl4)
- 6230-93-9Phosphonothioic acid,P-phenyl-, O-ethyl ester
- 875-83-22-Naphthalenol, sodiumsalt (1:1)
- 14383-51-88-Azabicyclo[3.2.1]octan-3-ol,hydrochloride (1:1), (3-endo)-
Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!
- Supplier Location:
China (Mainland)(14)
India(2)
United Kingdom(2)
United States(2)
- Business Type:
- Importer/Exporter(10)Lab/Research institutions(4)
- Certificates:
- ISO(1) Production License (0)
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Effect of 11-deoxycorticosterone acetate on the antineoplastic effect of thiophosphamide, chlorbutin, spirazidine, and prospidin under experimental conditions
- Effect of 11-deoxycorticosterone acetate on the antineoplastic effect of thiophosphamide, chlorbutin, spirazidine, and prospidin under experimental conditions. Grushina, A. A.Several substances are used for example 52-24-4 and 56-47-3 which are their cas registry numbers.; Kravchenko, A. I.; Sorkina, Yu. A.; Chernov, V. A. (Moscow, USSR). Tezisy Dokl. - Vses. Konf. Khimioter. Zlokach. Opukholei, 2nd, 169-70. Edited by: Astrakhan, V. I. Akad. Med. Nauk SSSR: Moscow, USSR. (Russian) 1974. CODEN: 34YKAH. DOCUMENT TYPE: Conference CA Section: 2 (Hormone Pharmacology) Doca (I) [56-47-3] (5-15 mg/day) given i.m. to rats for 8 days beginning 4-7 days after inoculation with sarcoma 45 stimulated tumor growth. It also stimulated tumor growth in adrenalectomized animals. I inhibited the antiblastic effects of thiophosphamide [52-24-4], chlorbutin [305-03-3], and prospidin [23476-83-7], particularly in adrenalectomized animals. I weakened the antineoplastic effect of spirazidine [1158-80-1] only in adrenalectomized animals. I decreased the toxicity of thiophosphamide but not that of the other neoplasm inhibitors studied. .
- Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs
- Correlations of alkylating activity and mutagenicity in bacteria of cytostatic drugs. Hemminki, Kari; Kallama, Seija; Falck, Kai (Inst. Occup. Health, Helsinki 00290/29, Finland). Acta Pharmacol. Toxicol., 53(5), 421-8 (English) 1983. CODEN: APTOA6. ISSN: 0001-6683. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) The alkylating activity of cytostatic drugs was studied in relation to their mutagenicity and toxicity in Escherichia coli WP2 uvrA. Four classes of directly acting cytostatic drugs were studied: N mustards (N mustard [55-86-7], melphalan [148-82-3], chlorambucil [305-03-3], and phosphoramide mustard [10159-53-2], a metabolite of cyclophosphamide), ethyleneimine derivs. (Thio-TEPA [52-24-4], TEPA [545-55-1], and triethylenemelamine [51-18-3]), busulfan [55-98-1], and halogenated nitrosoureas. The ref. compds. included Me methanesulfonate [66-27-3], ethyleneimine [151-56-4], and methylnitrosourea [684-93-5]. Guanosine [118-00-3] alkylation was detd. by fluorometry. The rate of guanosine and 4-(p-nitrobenzyl)pyridine [1083-48-3] alkylation agreed well. N mustard derivs. and triethylenemelamine were the most potent alkylating agents among the cytostatic drugs; N mustard was 5-10 times more active than Me methanesulfonate. Ethyleneimine derivs., busulfan, and the nitrosoureas were relatively weak alkylating agents. 66-27-3 and 55-98-1 are just another two chemicals used in this study. N mustard and triethylenemelamine were the most potent mutagens in bacteria; they were also among the most toxic drugs studied. .
- About us
- |
- Payment
- |
- Contact us
- |
- Links
- |
- Help Center
- |
- Disclaimer
- |
- Add to favorite
- | SiteMap
- |
- Product SiteMap
- |
- Manufacturers
- |
- Suppliers
©2008 LookChem.com,License:ICP NO.:Zhejiang10014259
[Hangzhou]86-571-85317600,85317603,85317620

